| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 7e-09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |